NuVasive‘s EVP, General Counsel & Secretary Jason Hannon sold 12,117 shares at an average price of $46.82 on Jan. 5. The total value of the transaction was $567,318 and now Mr. Hannon owns 32,240 shares valued at around $1.6 million, according to a Stafford Daily report.
Integra LifeSciences‘ Judith Ogrady sold 3,500 shares at $53.33 on Jan. 2. The transaction was worth $186,655, according to a Stafford Daily report.
Exactech Vice President, Administration Betty A. Petty sold 7,500 shares of the company’s stock at an average price of $22.30 on Jan. 2. The total transaction was worth $167,250, according to a Stafford Daily report.
More articles on orthopedic devices:
Benvenue Medical names Rick Simmons VP of sales & marketing
10 key notes from Implanet’s 2014 financial report—Revenue up 5%
Medtronic shareholders OK Covidien acquisition—5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
